Mariner
FOLD

Mariner’s Amicus Therapeutics FOLD Stock Holding History

Mariner’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,677
Closed -$522K – 3653
2025
Q4 		$522K Buy
36,677
+25,136
+218% +$247K ﹤0.01% 2417
2025
Q3 		$90.9K Buy
+11,541
New +$82.1K ﹤0.01% 3378
2025
Q1 		– Sell
-21,838
Closed -$206K – 3499
2024
Q4 		$206K Buy
21,838
+709
+3% +$7.37K ﹤0.01% 2975
2024
Q3 		$226K Sell
21,129
-9,077
-30% -$98.9K ﹤0.01% 2830
2024
Q2 		$300K Sell
30,206
-1,948
-6% -$20K ﹤0.01% 2453
2024
Q1 		$379K Buy
32,154
+241
+0.8% +$3.08K ﹤0.01% 2242
2023
Q4 		$453K Sell
31,913
-902
-3% -$10.2K ﹤0.01% 2006
2023
Q3 		$399K Sell
32,815
-1,868
-5% -$24.1K ﹤0.01% 1923
2023
Q2 		$436K Sell
34,683
-431
-1% -$5.11K ﹤0.01% 1842
2023
Q1 		$389K Buy
35,114
+942
+3% +$11.6K ﹤0.01% 1864
2022
Q4 		$417K Buy
34,172
+8,741
+34% +$98.4K ﹤0.01% 1773
2022
Q3 		$265K Buy
25,431
+188
+0.7% +$2.1K ﹤0.01% 1863
2022
Q2 		$271K Sell
25,243
-1,095
-4% -$9.02K ﹤0.01% 1310
2022
Q1 		$249K Buy
26,338
+3,539
+16% +$33.2K ﹤0.01% 1328
2021
Q4 		$263K Buy
+22,799
New +$254K ﹤0.01% 1120
2021
Q2 		– Sell
-20,607
Closed -$203K – 916
2021
Q1 		$203K Buy
+20,607
New +$319K ﹤0.01% 856
2017
Q1 		– Sell
-15,477
Closed -$77K – 601
2016
Q4 		$77K Buy
+15,477
New +$107K ﹤0.01% 546
2016
Q3 		– Sell
-70,602
Closed -$385K – 815
2016
Q2 		$385K Buy
+70,602
New +$494K 0.02% 377
2016
Q1 		– Sell
-25,206
Closed -$244K – 539
2015
Q4 		$244K Buy
+25,206
New +$227K 0.02% 372

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Mariner's FOLD Position: Q1 2026 in Review

Mariner sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 36,677 shares — an estimated $522K sold.

Mariner first reported a position in FOLD in Q4 2015 and held it in 19 quarters. The position peaked at $522K in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Mariner reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Mariner sold 36,677 Amicus Therapeutics shares in Q1 2026, an estimated $522K.
  • Mariner first reported a position in Amicus Therapeutics in Q4 2015 and held it in 19 quarters.
  • Mariner's Amicus Therapeutics position peaked at $522K in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.